Dermira dumps acne drug after phase 3 flubs by Amirah Al Idrus Monday, March 5, 2018 Dermira pulled the plug on olumacostat glasaretil when it failed to beat out placebo.
Roche in part-sale of mixed bag lebrikizumab to Dermira by Ben Adams Tuesday, August 8, 2017 Dermira will take on certain rights to lebrikizumab from Roche.
Dermira posts broadly positive results for excessive sweat drug by Ben Adams Thursday, June 2, 2016 The Californian biotech Dermira says its experimental sweat drug DRM04 passed one Phase III test but narrowly missed its target on a second--although analysts believe this will still be good enough to reap an FDA approval.
